Fusion Pharmaceuticals Inc (FUSN)
21.45
-0.04
(-0.19%)
USD |
NASDAQ |
May 03, 16:00
21.49
+0.04
(+0.19%)
After-Hours: 07:48
Fusion Pharmaceuticals Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 2.006M |
| June 30, 2023 | 0.034M |
| March 31, 2023 | 0.028M |
| December 31, 2022 | 0.14M |
| September 30, 2022 | 0.166M |
| Date | Value |
|---|---|
| June 30, 2022 | 0.57M |
| March 31, 2022 | 0.585M |
| December 31, 2021 | 0.594M |
| September 30, 2021 | 0.325M |
| June 30, 2021 | 0.521M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.028M
Minimum
Mar 2023
2.006M
Maximum
Sep 2023
0.4969M
Average
0.423M
Median
Revenue (Quarterly) Benchmarks
| AstraZeneca PLC | 12.68B |
| Landos Biopharma Inc | -- |
| Perspective Therapeutics Inc | -5.239M |
| Acasti Pharma Inc | -- |
| Aurinia Pharmaceuticals Inc | 45.10M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -28.18M |
| Total Expenses (Quarterly) | 28.28M |
| EPS Diluted (Quarterly) | -0.39 |
| Enterprise Value | 1.618B |
| Earnings Yield | -6.85% |
| Normalized Earnings Yield | -7.599 |